mRNA technologies showed great promise during the COVID-19 pandemic and the pharmaceutical community is finding new ways to harness this technology to advance medical therapies. However, traditional resin chromatography bottlenecks can slow down the purification of Plasmid DNA and mRNA that are critical to these processes.
Hear from Jin Zhou, PhD, Founder and Business Director of Purilogics by Donaldson, as he leads an in-depth discussion of the breakthrough Purexa™ novel membrane chromatography series. He will cover how this technology can enable the rapid purifications of plasmids and mRNA, utilizing affinity membrane adsorber technologies that offer significantly higher production.
Learn how this technology provides a new solution to the inefficiencies in traditional resin chromatography methods. Through supported data, Jin will demonstrate how using Purexa™ NAEX+ and MCP products can facilitate the fast and efficient purification of super coiled plasmid DNA. In addition, he will walk you through how Purexa™ OdT demonstrates superior performance in mRNA/IVT purification. Discover how the use of cutting-edge Purexa™ membrane chromatography products unlock higher binding capacity and short residual time while enabling consistency and scalability. Register NOW and determine how this easy-to-use technology can be utilized in your organization.
Key Learning Objectives:
- How membrane chromatography provides solutions to many inefficiencies experienced in traditional resin chromatography.
- How Purexa™ NAEX+ and MCP demonstrates fast and efficient purification of super coiled DNA.
- How Purexa™ OdT shows superior performance in mRNA/IVT Purification.
- How Purilogics products are tailored for high-throughput nucleic acid purification. increase mRNA purification production with novel membrane chromatography
